Ge healthcare announces prucka 3 digital amplifier as next generation platform for electrophysiology innovation

Chicago--(business wire)--ge healthcare (nasdaq: gehc) announces the latest innovation in electrophysiology (ep), the prucka 3 with cardiolab ep recording system, to help clinicians in the diagnosis and treatment of cardiac arrhythmias. cardiovascular disease is the leading cause of death globally - affecting millions of individuals and placing a significant burden on healthcare systems today. 1 within the complex umbrella of cardiology care and cardiovascular disease, atrial fibrillation (afib.
GEHC Ratings Summary
GEHC Quant Ranking